CDH5 and juvenile idiopathic arthritis: Nonetheless, given that the most recent guidelines of long-term care [24] recommend against adding chronic low-dose GCS in JIA patients regardless of the disease activity, such drawback of VE-cadherin may lose its importance in the future research.